Prepubertal acne: Clinical presentation, evaluation, and treatment

Journal of Cutaneous Medicine and Surgery

Volumn 2, Issue 3 SUPPL. 3, 1998, Pages

  Marcoux, Danielle ^a   McCuaig, Catherine C ^a   Powell, Julie ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ANDROGEN; ANTI ACNE AGENT; ANTIBIOTIC AGENT; AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN; CORTICOSTEROID; ERYTHROMYCIN; GLYCOLIC ACID; HYDROCORTISONE; ISOTRETINOIN; METRONIDAZOLE; NICOTINAMIDE; PRASTERONE SULFATE; RETINOIC ACID; SALICYLIC ACID; TAZAROTENE; TESTOSTERONE;

ACNE; ACNE VULGARIS; ARTICLE; CRYOTHERAPY; HUMAN; ORAL DRUG ADMINISTRATION; PHOTOTHERAPY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREPUBERTY; PRIORITY JOURNAL; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; TOPICAL DRUG ADMINISTRATION; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; HYPERANDROGENISM; INFANT; MALE; NEWBORN; PRESCHOOL CHILD; PUBERTY; REVIEW;

ACNE VULGARIS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERANDROGENISM; INFANT; INFANT, NEWBORN; MALE; PUBERTY;

EID: 0031778663     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Schachner LA, Hansen RC. Acne. In: Pediatrie dermatology. Vol 1. Neonatal and infantile acne. New York: Churchill Livingstone, 1988:685-686.
2. Jansen T, Burgdorf WHC, Plewig G. Pathogenesis and treatment of acne in childhood. Pediatr Dermatol 1997; 14:17-21.
3. Forest MG, Cathiard AM, Bertrand JA. Evidence of testicular activity in early infancy. J Clin Endocrinol Metab 1973; 37: 148-151.
4. Forest MG, Cathiard AM. Pattern of plasma testosterone and Δ-androstenedione in normal newborns. Evidence for testicular activity at birth. J Clin Endocrinol Metab 1975; 41:977-980.
5. Rapelanoro R, Mortureux P, Couprie B, et al. Neonatal Malassezia furfur pustulosis. Arch Dermatol 1996; 132:190-193.
6. Stankler L, Campbell AGM. Neonatal acne vulgaris: a possible feature of the fetal hydantoin syndrome. Br J Dermatol 1980; 103:453-455.
7. Smith RC, Dent J, Derbes V. Acneiform eruption on an infant after antepartum and neonatal cortisone therapy. Arch Dermatol Syph 1953; 67:630.
8. Tabata N, Terui T, Walanabe M. Infantile acne associated with a high plasma testosterone level in a 21-month-old boy. J Am Acad Dermatol 1995; 33:676-678.
9. Duke EMC. Infantile acne associated with transient increases in plasma concentrations of luteinising hormone follicle-stimultating hormone and testosterone. Br Med J 1981; 282:1275-1276.
10. Chew EW, Bingham A, Burrows D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp Dermatol 1990; 15:376-377.
11. Dupont C. A study of juvenile acne. Clin Exp Dermatol 1989; 14:175.
12. Wagner G, Schmidt KU, Mensing H. Acne conglobata infantum. Arch Dermatol 1987; 13:306-307.
13. Burket JM, Storrs FJ. Nodulocystic infantile acne occurring in a kindred of steatocystoma. Arch Dermatol 1987; 27:432-433.
14. Kligman AM. A critical look at acne cosmetica. J Cut Ag Cosm Dermatol 1988-89; 1:109-114.
15. Berlin C. Acne comedo in children due to paraffin oil applied on the head. Arch Dermatol 1955; 60:683-687.
16. Caputo R, Monti M, Ermacora E, et al. Cutaneous manifestations of tetrachlorodibenzo-p-dioxin in children and adolescents. J Am Acad Dermatol 1988; 19:812-819.
17. Passi S, Nazzaro-Porro M, Boniforti L, et al. Analysis of lipids and dioxin in chloracne due to tetrachloro-2,3,7,8-p-dibenzodioxin. Br J Dermatol 1981; 105:137-143.
18. Monk B, Cunliffe WJ, Layton AM, et al. Acne induced by inhaled corticosteroids. Clin Exp Dermatol 1993; 18:148-150.
19. Lucky AW, Biro FM, Huster GA, et al. Acne vulgaris in premenarchal girls: an early sign of puberty associated with rising levels of dehydroepiandrosterone. Arch Dermatol 1994; 130: 308-314.
20. Lucky AW, Biro FM, Simbartl LA, et al. Predictors of severity of acne vulgaris in young adolescent girls: results of a five year longitudinal study. J Pediatr 1997; 130:30-39.
21. Lucky AW, Biro FM, Huster GA. Acne vulgaris in early adolescent boys. Arch Dermatol 1991; 127:210-216.
22. Bork K. Cutaneous side effects of drugs. Philadelphia: WB Saunders, 1988:214-219.
23. Blatt J, Lee PA. Severe acne and hyperandrogenemia following dactinomycin. Med Pediatr Oncol 1993; 21:373-374.
24. De Raeve L, De Schepper JD, Smitz J. Prepubertal acne: a cutaneous marker of androgen excess? J Am Acad Dermatol 1995; 32: 181-184.
25. Kligman AM. The treatment of acne with topical retinoids: one man's opinions. J Am Acad Dermatol 1997; 36:S92-S95.
26. Korting HC, Ponce-Pöschl E, Klövekorn W, et al. The influence of the regular use of a soap or an acidic syndet bar on pre-acne. Infection 1995; 23:89-93.
27. Mander SM, Lucky AW. Perioral dermatitis in childhood. J Am Acad Dermatol 1992; 27:688-692.
28. Cunliffe WJ, Van de Kerkhoff PCM, Caputo R, et al. Roaccutane treatment guidelines: results of an international survey. Dermatology 1997; 194:351-357.
29. Arbegast KD, Braddock SW, Lamberty LF, Sawka AR. Treatment of infantile cystic acne with oral isotretinoin: a case report. Pediatr Dermatol 1997; 166-168.
30. Wang CM, Huang CL, Hu CT, Chan HL. The effect of glycolic acid on the treatment of acne in Asian skin. Dermatol Surg 1997; 23:23-29.
31. Cunliffe WJ, Caputo R, Dreno B, et al. Efficacy and safety comparison of adapalene (CD 271) gel and tretinoin gel in the topical treatment of acne vulgaris. A European multicentre trial. J Dermatol Treat 1997; 8:173-178.
32. Shalita A, Weiss JS, Chalker DK, et al. A comparison of the efficacy and safety of adapalene gel 0.1% (differin) and tretinoin gel 0.025% in the treatment of acne vulgaris. J Am Acad Dermatol 1996; 34:482-485.
33. Graupe K, Cunliffe WJ, Gollnick HPM, Zaumseil RP. Efficacy and safety of topical azelaic acid (20% cream): an overview of results from European clinical trials and experimental reports. Cutis 1996; 557:20-35.
34. Weiss JS. Current options for the topical treatment of acne vulgaris. Pediatr Dermatol 1996; 34:480-488.
35. Eady EA, Bojar RA, Jones CE, et al. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol 1996; 134:107-113.
36. Pierard GE. Le benzamycin, une actualisation du traitement topique de l'acné. Rev Med Liege 1997; 52:120-122.
37. Chu A, Huber FJ, Plott RT. The comparative efficacy of benzoyl peroxide 5%/erythromycin 3% gel and erythromycin 4%/zinc 1-2% solution in the treatment of acne vulgaris. Br J Dermatol 1997; 136:235-238.
38. Lookingbill DP, Chalker DK, Lindholm JS, et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 1997; 37:590-595.
39. Shalita AR, Smith JG, Parish LC et al. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol 1995; 34:434-437.
40. van Weelden H, de Gruyl FR, Van der Putte SCJ, et al. The carcinogenic risk of modern tanning equipment: is UVA safer than UVB? Arch Dermatol Res 1988; 280:300-307.
41. Sigurdsson V, Knulst AC, van Weelden H. Phototherapy of acne vulgaris with visible light. Dermatology 1997; 194:256-260.
42. Stafstrom C. Erythromycin-induced carbamazepine toxicity: a continuing problem. Arch Pediatr Adolesc Med 1995; 149:99-100.
43. Clark SM, Cunliffe WJ. The use of isotretinoin in the treatment of acne in children. Br J Dermatol 1995; 133:39.
44. Layton AM, Stainforth JM, Cunliffe WJ. Isotretinoin for acne vulgaris. Ten years later: a safe and successful treatment. Br J Dermatol 1993; 129:292-296.
45. Earth JH. Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol 1993; 129:704-707.